analys
identifi
differ
membraneact
region
hepat
c
viru
hcv
core
protein
observ
effect
corederiv
peptid
librari
two
hcv
strain
integr
differ
membran
model
system
addit
studi
secondari
structur
specif
membraneinteract
peptid
hcv
core
protein
aqueou
solut
presenc
model
membran
system
result
show
hcv
core
protein
region
compris
cterminu
domain
nterminu
domain
seem
activ
membran
interact
although
role
proteinprotein
interact
exclud
significantli
secondari
structur
nearli
assay
peptid
chang
presenc
model
membran
sequenc
probabl
play
relev
part
biolog
action
hcv
lipid
interact
furthermor
membranotrop
region
could
envisag
new
possibl
target
inhibit
interact
membran
could
potenti
lead
new
vaccin
strategi
hepat
c
viru
hcv
envelop
posit
singlestrand
rna
viru
belong
genu
hepaciviru
famili
flavivirida
lead
caus
acut
chronic
liver
diseas
human
includ
chronic
hepat
cirrhosi
hepatocellular
carcinoma
exist
vaccin
prevent
hcv
infect
current
therapeut
agent
limit
success
hcv
hcv
genom
consist
one
translat
open
read
frame
encod
polyprotein
precursor
includ
structur
nonstructur
protein
cleav
host
viral
proteas
fig
structur
protein
consist
core
protein
form
viral
nucleocapsid
envelop
glycoprotein
transmembran
protein
hcv
cell
entri
achiev
fusion
viral
cellular
membran
morphogenesi
virion
bud
suggest
take
place
endoplasm
reticulum
hcv
protein
sensit
fold
assembl
mutat
delet
besid
hcv
genom
wide
heterogen
error
replic
caus
high
rate
mutat
therefor
region
implic
fusion
andor
bud
must
interact
membran
conserv
sequenc
find
proteinmembran
proteinprotein
interact
inhibitor
could
good
strategi
hcv
infect
might
prove
potenti
therapeut
agent
hcv
core
protein
highli
basic
show
homolog
nucleocapsid
protein
flavivirus
protein
well
conserv
among
differ
hcv
strain
import
hcv
infect
diagnosi
detect
either
specif
antihcv
core
protein
antibodi
circulatori
viral
antigen
core
protein
regulatori
role
cell
function
like
immun
present
apoptosi
lipid
metabol
transcript
addit
protein
oncogen
potenti
play
import
role
regul
hcvinfect
cell
growth
transform
tumorigen
phenotyp
develop
hepatocellular
carcinoma
recombin
cdna
express
studi
protein
identifi
two
major
protein
core
speci
later
predomin
speci
abbrevi
cf
chol
cholesterol
epc
egg
lphosphatidylcholin
hcv
hepat
c
viru
luv
larg
unilamellar
vesicl
mlv
multilamellar
vesicl
nbdpe
n
nrhbpe
lissamin
tm
rhodamin
b
sm
egg
sphingomyelin
temperatur
gelliquid
crystallin
phase
transit
found
viral
particl
infect
sera
probabl
matur
form
protein
although
three
dimension
structur
protein
unknown
three
distinct
domain
consid
fulllength
immatur
protein
ie
domain
compris
amino
acid
sever
posit
charg
involv
rna
bind
includ
immunodomin
antigen
site
domain
compris
amino
acid
put
respons
associ
lipid
droplet
domain
compris
amino
acid
signal
peptid
upstream
glycoprotein
significantli
matur
core
protein
dimer
helic
protein
exhibit
membran
protein
featur
recent
identifi
membraneact
region
human
immunodefici
viru
hiv
sever
acut
respiratori
syndrom
coronaviru
sarscov
spike
hcv
glycoprotein
observ
effect
glycoproteinderiv
peptid
librari
model
membran
integr
result
permit
us
suggest
possibl
locat
differ
segment
protein
might
implic
proteinlipid
proteinprotein
interact
help
us
understand
process
give
rise
interact
protein
membran
addit
hcv
membran
assembl
bud
attract
target
antihcv
therapi
propos
core
protein
import
role
viral
assembl
investig
structur
basi
protein
core
interact
membran
identifi
new
target
search
viral
assembl
inhibitor
analys
identifi
differ
membraneact
region
hcv
core
protein
observ
effect
corederiv
peptid
librari
two
hcv
strain
name
hcv
hcv
integr
differ
membran
model
system
furthermor
studi
secondari
structur
specif
membraneinteract
peptid
aqueou
solut
presenc
model
membran
system
understand
molecular
mechan
viral
bud
well
make
possibl
futur
develop
hcv
assembl
inhibitor
may
lead
new
vaccin
strategi
egg
lphosphatidylcholin
epc
egg
sphingomyelin
sm
liver
lipid
extract
chloroform
methanol
extract
liver
tissu
cholesterol
chol
obtain
avanti
polar
lipid
alabast
al
usa
cf
high
perform
liquid
chromatographi
b
fig
scheme
hepat
c
viru
hcv
structur
nonstructur
protein
accord
literatur
consensu
sequenc
rel
locat
twentyseven
peptid
deriv
hcv
core
protein
shown
respect
sequenc
protein
maximum
overlap
adjac
peptid
amino
acid
b
analysi
hydrophob
interfaci
distribut
accord
scale
wimley
white
use
window
amino
acid
along
hcv
core
sequenc
without
assumpt
secondari
structur
sodium
dithionit
sigmaaldrich
madrid
spain
lissamin
rhodamin
b
nrhbpe
n
nbdpe
obtain
molecular
probe
inc
eugen
usa
three
set
peptid
deriv
core
protein
fig
hepat
c
viru
strain
acid
overlap
sequenti
peptid
obtain
nih
aid
research
refer
reagent
program
divis
aid
niaid
nih
bethesda
md
usa
reagent
use
analyt
grade
sigmaaldrich
water
deoniz
twicedistil
pass
milliq
equip
millipor
madrid
spain
resist
better
mw
cm
infrar
spectroscopi
aliquot
contain
appropri
amount
lipid
chloroformmethanol
vv
place
test
tube
contain
lg
dri
lyophil
peptid
obtain
final
lipidpeptid
mole
ratio
vortex
solvent
remov
evapor
stream
free
nitrogen
final
trace
solvent
elimin
vacuum
dark
h
sampl
hydrat
buffer
contain
hepe
nacl
mm
edta
ph
incub
gel
liquidcrystallin
phase
transit
temperatur
phospholipid
mixtur
intermitt
vortex
min
hydrat
sampl
obtain
multilamellar
vesicl
mlv
sampl
frozen
thaw
five
time
ensur
complet
homogen
maxim
peptidelipid
contact
occasion
vortex
final
suspens
centrifug
rpm
min
remov
peptid
possibl
unbound
membran
pellet
resuspend
buffer
phospholipid
peptid
concentr
measur
method
describ
previous
aliquot
contain
appropri
amount
lipid
chloroformmethanol
vv
place
test
tube
solvent
remov
evapor
stream
free
nitrogen
final
trace
solvent
elimin
vacuum
dark
h
assay
vesicl
leakag
ph
buffer
contain
trishcl
nacl
cf
mm
edta
ph
use
obtain
mlv
ml
buffer
ad
dri
phospholipid
mixtur
vortex
room
temperatur
clear
suspens
obtain
larg
unilamellar
vesicl
luv
mean
diamet
nm
prepar
mlv
extrus
method
use
polycarbon
filter
pore
size
lm
nuclepor
corp
cambridg
ca
usa
breakdown
vesicl
membran
lead
content
leakag
nonencapsul
cf
separ
vesicl
suspens
sephadex
filtrat
column
pharmacia
uppsala
sweden
elut
buffer
contain
either
trishcl
nacl
mm
edta
ph
membran
ruptur
leakag
intraliposom
cf
assay
treat
probeload
liposom
final
lipid
concentr
mm
appropri
amount
peptid
microtitr
plate
use
micropl
reader
fluostar
bmg
labtech
offenburg
germani
stabil
appropri
amount
peptid
well
contain
final
volum
medium
microtitr
plate
continu
stir
allow
rapid
mix
peptid
vesicl
leakag
assay
chang
fluoresc
obtain
chang
fluoresc
intens
record
excit
emiss
wavelength
set
nm
respect
excit
emiss
slit
set
nm
one
hundr
per
cent
releas
achiev
ad
triton
microtit
plate
final
concentr
wt
wt
fluoresc
measur
made
initi
probeload
liposom
afterward
ad
peptid
solut
final
ad
triton
obtain
leakag
leakag
quantifi
percentag
basi
accord
equat
f
f
equilibrium
valu
fluoresc
peptid
addit
f
initi
fluoresc
vesicl
suspens
f
fluoresc
valu
addit
triton
peptideinduc
vesicl
lipid
mix
hemifus
measur
reson
energi
transfer
assay
base
decreas
reson
energi
transfer
two
probe
nbdpe
rhbpe
lipid
probecontain
vesicl
allow
mix
lipid
vesicl
lack
probe
concentr
fluoresc
probe
within
liposom
membran
mol
assay
lipid
mix
ml
buffer
hepe
mm
nacl
ph
ad
dri
phospholipid
mixtur
contain
either
mol
nbdpe
nrhbpe
mol
nbdpe
nrhbpe
probe
mlv
obtain
vortex
room
temperatur
luv
prepar
mlv
extrus
method
use
polycarbon
filter
pore
size
lm
nuclepor
corp
use
lm
pores
filter
give
place
larger
liposom
henceforth
greater
fluoresc
intens
per
surfac
unit
label
unlabel
vesicl
proport
place
mm
fluoresc
cuvett
final
lipid
concentr
lm
final
volum
stabil
constant
stir
fluoresc
measur
use
varian
cari
eclips
fluoresc
spectromet
use
nm
nm
excit
emiss
respect
excit
emiss
slit
set
nm
label
unlabel
vesicl
mix
proport
respect
phospholipid
mix
estim
liposom
prepar
membran
concentr
probe
phospholipid
mix
quantifi
percentag
basi
accord
equat
f
f
equilibrium
valu
fluoresc
peptid
addit
liposom
mixtur
contain
liposom
probe
plu
liposom
without
fluoresc
probe
f
initi
fluoresc
vesicl
f
fluoresc
valu
liposom
contain
probe
peptideinduc
phospholipidmix
fusion
inner
monolay
measur
modif
phospholipidmix
measur
state
luv
treat
sodium
dithionit
complet
reduc
nbdlabel
phospholipid
locat
outer
monolay
membran
final
concentr
sodium
dithionit
mm
stock
solut
dithionit
tri
ph
incub
approxim
h
ice
dark
sodium
dithionit
remov
size
exclus
chromatographi
sephadex
filtrat
column
pharmacia
uppsala
sweden
elut
buffer
contain
tri
nacl
mm
edta
ph
proport
label
unlabel
vesicl
lipid
concentr
experiment
measur
condit
indic
phospholipid
mix
assay
approxim
pellet
sampl
place
two
caf
window
separ
thick
teflon
spacer
liquid
demount
cell
harrick
ossin
ny
usa
spectra
obtain
bruker
spectromet
bruker
ettlingen
germani
use
deuter
triglycin
sulphat
detector
spectrum
obtain
collect
interferogram
nomin
resolut
cm
transform
use
triangular
apod
averag
background
spectra
sampl
spectra
time
sampl
shuttl
accessori
use
obtain
sampl
background
spectra
spectromet
continu
purg
dri
air
dew
point
remov
atmospher
water
vapour
band
interest
sampl
equilibr
lowest
temperatur
min
acquisit
extern
bath
circul
connect
infrar
spectromet
control
sampl
temperatur
temperatur
studi
sampl
scan
use
interv
delay
consecut
scan
subtract
buffer
spectra
taken
temperatur
sampl
perform
interact
use
either
spectracalc
galact
industri
salem
usa
describ
previous
frequenc
centr
graviti
necessari
measur
take
top
point
specif
band
fit
gaussian
band
criterion
use
buffer
subtract
co
amid
region
remov
band
near
cm
flat
baselin
cm
peptid
librari
use
studi
correl
hcv
core
protein
sequenc
depict
fig
observ
peptid
librari
includ
whole
hcv
core
protein
sequenc
two
three
consecut
peptid
librari
overlap
amino
acid
respect
analysi
hydrophob
interfaci
distribut
along
core
sequenc
hcv
strain
data
obtain
hcv
strain
nearli
ident
without
assumpt
secondari
structur
shown
fig
although
three
dimension
structur
core
protein
known
data
give
us
depict
potenti
surfac
zone
could
possibl
implic
either
modul
membran
bind
proteinprotein
interact
observ
fig
evid
exist
differ
region
larg
hydrophob
interfaci
valu
along
core
sequenc
surfac
biolog
function
role
patch
posit
hydrophob
interfaci
along
surfac
core
protein
could
favour
interact
similar
patch
along
core
protein
differ
protein
surfac
membran
studi
effect
peptid
librari
deriv
hcv
core
protein
strain
membran
ruptur
ie
leakag
differ
liposom
composit
fig
lipid
composit
model
membran
epcchol
phospholipid
molar
ratio
epcsm
phospholipid
molar
ratio
epcsmchol
phospholipid
molar
ratio
lipid
extract
liver
membran
contain
epc
pe
chol
phosphatidylinositol
pi
lysophosphatidylcholin
lpc
neutral
lipid
presenc
sm
chol
relat
occurr
later
segreg
membran
microdomain
found
import
relationship
membran
interact
chol
sm
membran
content
sever
virus
peptid
assay
epcchol
liposom
peptid
exert
signific
leakag
effect
fig
f
remark
effect
induc
fig
g
similar
pattern
liposom
contain
epc
chol
found
notabl
effect
induc
peptid
compris
residu
wherea
peptid
strain
peptid
strain
elicit
also
signific
leakag
valu
liposom
compos
lipid
extract
liver
membran
peptid
sequenc
display
signific
leakag
valu
fig
h
found
signific
valu
found
peptid
compris
residu
peptid
show
also
signific
leakag
peptid
strain
peptid
strain
display
signific
leakag
valu
core
deriv
peptid
strain
assay
hemifus
epcsmchol
liver
extract
liposom
peptid
compris
residu
display
signific
valu
fig
b
peptid
elicit
import
hemifus
valu
defin
region
compris
amino
acid
hemifus
valu
rang
slightli
lower
hemifus
valu
found
corederiv
peptid
strain
strain
use
type
liposom
epc
sm
chol
liver
extract
fig
f
corederiv
peptid
strain
assay
fusion
epcsmchol
liver
extract
liposom
peptid
compris
residu
one
display
signific
fusion
valu
fig
g
h
region
compris
amino
acid
five
peptid
total
also
found
rel
high
hemifus
fusion
valu
strain
summari
membran
leakag
membran
hemifus
membran
fusion
result
obtain
strain
present
fig
wherea
global
averag
result
display
fig
possibl
detect
variou
segment
larg
leakag
valu
coincid
segment
display
signific
hemifus
fusion
valu
howev
also
possibl
detect
segment
display
high
hemifus
fusion
valu
low
leakag
one
result
permit
us
studi
specif
peptid
compris
differ
zone
infrar
spectroscopi
shown
peptid
display
signific
leakag
hemifus
fusion
effect
fig
ie
peptid
correspond
sequenc
chosen
structur
infrar
assay
aqueou
solut
aqueou
solut
peptid
addit
contain
trifluoroethanol
tfe
presenc
membran
model
system
compos
either
epcsmchol
molar
ratio
liver
lipid
extract
fig
spectra
obtain
five
differ
temperatur
signific
differ
found
indic
high
degre
conform
stabil
peptid
simplic
describ
spectra
obtain
assign
amid
compon
band
specif
structur
featur
describ
previous
observ
fig
signific
chang
amid
envelop
band
depend
peptid
specif
lipid
composit
use
amid
band
peptid
deriv
core
region
aqueou
solut
fig
display
narrow
band
cm
shoulder
least
two
broad
band
cm
band
envelop
amid
band
peptid
bound
raft
model
membran
significantli
differ
found
peptid
aqueou
solut
maximum
band
appear
cm
small
band
cm
fig
presenc
liver
lipid
extract
membran
amid
band
similar
one
found
presenc
raftcontain
membran
intens
band
cm
differ
band
intens
peptid
would
impli
bturn
signific
secondari
structur
aqueou
solut
wherea
presenc
raft
liver
extract
model
membran
signific
one
bsheet
amid
band
peptid
deriv
core
sequenc
aqueou
solut
display
broad
band
maximum
cm
shoulder
cm
fig
band
envelop
amid
band
peptid
bound
raft
model
membran
significantli
differ
found
peptid
aqueou
solut
maximum
band
appear
cm
small
shoulder
cm
presenc
model
membran
compos
liver
lipid
extract
amid
band
peptid
display
maximum
cm
intens
maxima
core
sequenc
would
impli
signific
structur
aqueou
solut
presenc
liposom
compos
liver
extract
random
bsheet
presenc
epcsmchol
molar
ratio
peptid
deriv
core
sequenc
strain
similar
sequenc
cystein
present
posit
strain
replac
aqueou
solut
peptid
show
rel
broad
amid
band
maximum
approxim
cm
shoulder
cm
much
intens
peptid
deriv
strain
one
fig
presenc
raft
model
membran
maximum
amid
band
case
shift
lower
wavenumb
display
amid
maxima
cm
shoulder
cm
presenc
liver
lipid
extract
membran
amid
band
peptid
display
broad
band
maximum
cm
differ
band
intens
would
impli
disord
structur
signific
secondari
structur
aqueou
solut
deriv
peptid
random
bturn
peptid
howev
presenc
raft
liver
extract
model
membran
signific
one
either
disord
structur
andor
bsheet
amid
band
peptid
deriv
core
sequenc
aqueou
solut
display
narrow
band
cm
shoulder
cm
fig
f
band
envelop
amid
band
peptid
bound
raft
model
membran
significantli
differ
found
peptid
aqueou
solut
maximum
band
appear
cm
shoulder
cm
presenc
model
membran
compos
liver
lipid
extract
amid
band
peptid
rather
similar
one
found
presenc
raft
membran
band
cm
present
higher
intens
differ
band
intens
core
sequenc
would
impli
bturn
signific
secondari
structur
aqueou
solut
togeth
random
structur
wherea
presenc
raft
liver
extract
model
membran
predomin
secondari
structur
bhelix
follow
bturn
viral
morphogenesi
one
import
step
viral
cycl
involv
lipid
membran
well
associ
endoplasm
reticulum
er
mithocondri
membran
g
maxim
hemifus
fusion
activ
see
result
section
part
hcv
major
antigen
domain
sequenc
expos
region
proteinmembran
interact
h
sequenc
low
constant
ruptur
hemifus
fusion
properti
see
result
section
character
fusion
event
envelop
virus
assembl
virion
take
place
host
cell
membran
case
hcv
suggest
viru
particl
assembl
occur
endoplasm
reticulum
membran
core
protein
might
play
central
role
viral
particl
format
well
might
drive
bud
process
significantli
hcv
core
protein
well
conserv
among
differ
hcv
strain
import
regulatori
role
differ
cell
function
interestingli
hcv
core
protein
report
associ
raft
subdomain
absenc
viral
nonstructur
protein
raft
rigid
membran
subdomain
locat
predominantli
plasma
membran
describ
import
hcv
replic
cycl
assembl
virion
bud
host
cell
reason
chosen
membran
model
system
compos
liver
lipid
extract
also
epc
sm
chol
mimet
model
membran
contain
raft
domain
biolog
role
hcv
core
protein
modul
membran
identifi
membraneact
region
hcv
core
protein
studi
effect
two
corederiv
peptid
librari
hcv
integr
membran
model
system
furthermor
obtain
inform
structur
basi
interact
protein
model
membran
studi
secondari
structur
specif
membraneinteract
peptid
aqueou
solut
presenc
model
membran
system
way
would
possibl
identifi
import
region
might
implic
bud
molecular
mechan
therefor
could
use
new
target
search
viral
assembl
inhibitor
well
make
possibl
futur
develop
hcv
assembl
inhibitor
may
lead
new
vaccin
strategi
observ
fig
b
abl
discern
differ
zone
along
core
sequenc
display
differ
membranotrop
properti
leakag
assay
valu
taken
account
membran
composit
assay
two
zone
display
signific
membran
ruptur
activ
ie
region
defin
amino
acid
first
region
display
high
interfaci
valu
along
sequenc
howev
second
one
show
signific
hydrophob
interfaci
valu
context
interest
note
region
compris
residu
describ
import
homotyp
interact
might
prerequisit
assembl
bud
hcvlike
viral
particl
significantli
mutant
core
protein
without
amino
acid
residu
reduc
abolish
associ
lipid
droplet
interestingli
interact
region
compos
amino
acid
glycoprotein
describ
region
might
also
import
associ
endoplasm
reticulum
mitochondri
outer
membran
notabl
region
coincid
hydrophob
cluster
locat
domain
core
protein
region
partial
overlap
anoth
one
locat
domain
infrar
spectroscopi
possibl
observ
region
display
differ
type
secondari
structur
random
structur
major
one
aqueou
solut
increas
bsheet
presenc
model
membran
observ
although
region
present
high
level
membran
ruptur
hemifus
fusion
whole
protein
context
region
might
implic
protein
homodimer
proteinmembran
interact
sequenc
apart
one
elicit
leakag
effect
display
also
signific
hemifus
fusion
activ
region
display
highest
hemifus
fusion
valu
togeth
lowleakag
valu
fig
observ
fig
region
display
high
hydrophob
interfaci
valu
along
sequenc
infrar
spectroscopi
determin
aqueou
solut
predomin
secondari
structur
bturn
bsheet
presenc
model
membran
compos
either
raft
liver
extract
lipid
region
two
sequenti
glycin
might
confer
high
flexibl
peptid
might
act
hing
around
conform
could
chang
moreov
region
part
hcv
major
antigen
domain
sequenc
probabl
expos
implic
proteinmembran
interact
hand
demonstr
uniformli
pack
viru
particl
gener
segment
compos
amino
acid
residu
wherea
region
one
ntermin
half
core
protein
found
interact
lipid
reason
region
might
import
one
hcv
assembl
anoth
interest
core
sequenc
pertain
region
display
low
constant
membran
ruptur
hemifus
fusion
activ
fig
describ
abil
core
protein
associ
lipid
droplet
lost
region
contain
yatg
motif
delet
region
low
signific
membraneact
activ
might
implic
interact
membran
addit
role
viral
morphogenesi
bud
core
protein
also
import
disassembl
event
viral
uncoat
occur
target
cell
postfus
stage
reason
protein
flexibl
predict
structur
whole
protein
use
circular
dichroism
cd
indic
protein
bhelix
structur
bsheet
structur
bturn
random
coil
wherea
ctermin
truncat
protein
larg
unord
shown
work
nearli
peptid
assay
display
major
random
coil
turn
structur
solut
howev
structur
chang
presenc
model
membran
inform
could
suggest
membranotrop
region
detect
along
core
sequenc
might
involv
interact
membran
also
protein
even
core
protein
therefor
respons
oligomer
altogeth
result
show
hcv
core
protein
membraneact
region
present
work
locat
domain
fig
whatev
interact
paramet
consid
howev
preval
idea
domain
might
rnabind
region
wherea
domain
hcv
core
protein
would
respons
membranebind
domain
signal
peptid
gather
relat
result
literatur
clear
domain
vs
domain
reason
appropri
unravel
foundat
hcv
coreprotein
interact
lipid
region
compris
cterminu
domain
nterminu
domain
seem
activ
membran
interact
although
role
proteinprotein
interact
exclud
sequenc
domain
maxim
fusion
hemifus
sequenc
f
fig
belong
major
antigen
sequenc
hcv
sequenc
probabl
play
part
biolog
action
hcv
lipid
interact
whether
assembl
fusion
exhaust
studi
lipidpeptid
interact
might
help
understand
hcv
bud
molecular
mechan
well
make
possibl
futur
develop
antihcv
drug
target
bud
membranotrop
region
could
envisag
new
possibl
target
inhibit
interact
membran
could
potenti
lead
new
vaccin
strategi
